Selegiline (l-deprenyl, Eldepryl, Zelapar, or Anipryl veterinary)'s a drug used for the treatment of early-stage Parkinson's disease, depression and senile dementia. In normal clinical doses it's a selective irreversible MAO-B inhibitor, however in larger doses it loses its specificity and also inhibits MAO-A. Dietary restrictions are common for MAOI treatments, but special dietary restrictions for lower doses have been found to be unnecessary. The drug was researched by Jozsef Knoll et al. (Hu… (More on Deprenyl)